Newsroom

After a diagnosis of childhood cancer, Ryan faced the diagnosis and treatment of leukemia head- on with the support of his family and community.

The race is on to find a new treatment before resistance to today’s drugs becomes widespread.

Novartis collaborates with Homology Medicines to adapt and refine genome editing technology.

Ron Hollander, president of the International Neuroendocrine Cancer Alliance, talks to us about patient advocacy.

Early clinical trial reports results in this hidden disease

New Global Head of Cardiovascular and Metabolic Diseases Research looks to apply new tools to address tough challenges.

New Global Head of Ophthalmology Research sees the eye as a frontier of biomedical research.

Novartis researchers want to use the technology to help them design new drugs.

On Friday nights, Juan Pedro García Hernández goes dancing – but for rest of the time he’s taking care of his mother.

A researcher in South Africa investigating a rare skin disease was losing hope of a breakthrough. Then she made a discovery.

In Australia, a country where skin cancer rates remain high, cancer survivor Malcolm Caddies is on a mission to prevent the risks of sun exposure.

Ice hockey used to help Tyler Patron combat cystic fibrosis, but he hopes the lab could yield stronger medicine.